| For: | Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases 2015; 3(7): 607-613 [PMID: 26244152 DOI: 10.12998/wjcc.v3.i7.607] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v3/i7/607.htm |
| Number | Citing Articles |
| 1 |
Qilan Hu, Yiqi Hu, Huiyang Ai, Liming Xia, Rong Liu, Tao Ai. Pre-operative MRI in evaluating pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer: a study focused on influencing factors of baseline clinical-pathological and imaging features. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1366613
|
| 2 |
Erika Marina Solla Negrão, Almir Galvão Vieira Bitencourt, Juliana Alves de Souza, Elvira Ferreira Marques. Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer center. Radiologia Brasileira 2019; 52(5) doi: 10.1590/0100-3984.2018.0149
|
| 3 |
|
| 4 |
Marie-Pierre Chauvet. Nouvelle chirurgie du cancer du sein. La Presse Médicale 2019; 48(10) doi: 10.1016/j.lpm.2019.08.020
|
| 5 |
Devan Diwanji, Natsuko Onishi, Deep K. Hathi, Courtney Lawhn-Heath, John Kornak, Wen Li, Ruby Guo, Julissa Molina-Vega, Youngho Seo, Robert R. Flavell, Diane Heditsian, Susie Brain, Laura J. Esserman, Bonnie N. Joe, Nola M. Hylton, Ella F. Jones, Kimberly M. Ray. 18F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant Chemotherapy. Radiology: Imaging Cancer 2024; 6(2) doi: 10.1148/rycan.230082
|
| 6 |
M. P. Chauvet, A. Mailliez. Chimiothérapie néoadjuvante : pour qui ?. Oncologie 2016; 18(2-3) doi: 10.1007/s10269-016-2590-z
|
| 7 |
Nathaniel M. Braman, Maryam Etesami, Prateek Prasanna, Christina Dubchuk, Hannah Gilmore, Pallavi Tiwari, Donna Plecha, Anant Madabhushi. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Research 2017; 19(1) doi: 10.1186/s13058-017-0846-1
|
| 8 |
Alison S. Baskin, Laura A. Huppert, Tatiana Kelil, Lisa Singer, Rita A. Mukhtar. The neoadjuvant approach to treatment of breast cancer: Multidisciplinary management to improve outcomes. Surgical Oncology Insight 2024; 1(2) doi: 10.1016/j.soi.2024.100059
|
| 9 |
Yanding Zhao, Evelien Schaafsma, Chao Cheng. Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy. Cancer Medicine 2020; 9(17) doi: 10.1002/cam4.3284
|
| 10 |
Valentina Giannini, Simone Mazzetti, Agnese Marmo, Filippo Montemurro, Daniele Regge, Laura Martincich. A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features. The British Journal of Radiology 2017; 90(1077) doi: 10.1259/bjr.20170269
|
| 11 |
Erika M.S. Negrão, Juliana A. Souza, Elvira F. Marques, Almir G.V. Bitencourt. Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy. European Journal of Radiology 2019; 120 doi: 10.1016/j.ejrad.2019.108701
|
| 12 |
K. K. Rajan, C. Boersma, M. A. Beek, T. A. Berendsen, J. van der Starre-Gaal, M. van ’t Veer-ten Kate, A. B. Francken, E. M. Noorda. Optimizing surgical strategy in locally advanced breast cancer: a comparative analysis between preoperative MRI and postoperative pathology after neoadjuvant chemotherapy. Breast Cancer Research and Treatment 2024; 203(3) doi: 10.1007/s10549-023-07122-8
|
| 13 |
Yireh Han, Ji Gwang Jung, Jang-il Kim, Changjin Lim, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han. The percentage of unnecessary mastectomy due to false size prediction using preoperative ultrasonography and MRI in breast cancer patients who underwent neoadjuvant chemotherapy: a prospective cohort study. International Journal of Surgery 2023; 109(12) doi: 10.1097/JS9.0000000000000754
|
| 14 |
P. Taourel, E. Pages, I. Millet, C. Bourgier, P. Rouanet, W. Jacot, P. Crochet, D. Azria. Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy. Critical Reviews in Oncology/Hematology 2018; 132 doi: 10.1016/j.critrevonc.2018.09.012
|
| 15 |
Zhenyu Liu, Zhuolin Li, Jinrong Qu, Renzhi Zhang, Xuezhi Zhou, Longfei Li, Kai Sun, Zhenchao Tang, Hui Jiang, Hailiang Li, Qianqian Xiong, Yingying Ding, Xinming Zhao, Kun Wang, Zaiyi Liu, Jie Tian. Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study. Clinical Cancer Research 2019; 25(12) doi: 10.1158/1078-0432.CCR-18-3190
|
| 16 |
Apinya Iamsamang, Shanigarn Thiravit, Voraparee Suvannarerg, Pradit Rushatamukayanunt, Pornpim Korpraphong, Suebwong Chuthapisith, Waraporn Imruetaicharoenchoke. Accuracy of Breast Magnetic Resonance Imaging (MRI) and Breast Ultrasound Compared to Pathology in Assessing Residual Tumor in Breast Cancer Patients Receiving Neoadjuvant Systemic Treatment at Siriraj Hospital. Siriraj Medical Journal 2025; 77(9) doi: 10.33192/smj.v77i9.276157
|
| 17 |
Caitlin Murphy, Violet Mukaro, Robert Tobler, Rebecca Asher, Emma Gibbs, Linda West, Bruno Giuffre, Sally Baron‐Hay, Mustafa Khasraw. Evaluating the role of magnetic resonance imaging post‐neoadjuvant therapy for breast cancer in the NEONAB trial. Internal Medicine Journal 2018; 48(6) doi: 10.1111/imj.13617
|
| 18 |
Hongyi Dammu, Thomas Ren, Tim Q. Duong, Sriparna Saha. Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients. PLOS ONE 2023; 18(1) doi: 10.1371/journal.pone.0280148
|
| 19 |
H. Cain, I.R. Macpherson, M. Beresford, S.E. Pinder, J. Pong, J.M. Dixon. Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in Practice. Clinical Oncology 2017; 29(10) doi: 10.1016/j.clon.2017.06.003
|
| 20 |
Rita A. Mukhtar, Harrison Chau, Hannah Woriax, Mara Piltin, Gretchen Ahrendt, Julia Tchou, Hongmei Yu, Qian Ding, Catherine Lu Dugan, Jori Sheade, Angelena Crown, Michael Carr, Jasmine Wong, Jennifer Son, Rachel Yang, Theresa Chan, Alicia Terando, Michael Alvarado, Cheryl Ewing, Jennifer Tonneson, Nina Tamirisa, Rebekah Gould, Puneet Singh, Constantine Godellas, Kelsey Larson, Akiko Chiba, Roshni Rao, Candice Sauder, Lauren Postlewait, Marie Catherine Lee, William Fraser Symmans, Laura J. Esserman, Judy C. Boughey. Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy. Annals of Surgery 2023; 278(3) doi: 10.1097/SLA.0000000000005968
|
| 21 |
Shahine Goulam-Houssein, Xiang Y. Ye, Rachel Fleming, Frederick Au, Supriya Kulkarni, Sandeep Ghai, Yoav Amitai, Michael Reedijk, Vivianne Freitas. Evaluating persistent T1-weighted lesions without concurrent abnormal enhancement on breast MRI in neoadjuvant chemotherapy patients: implications for complete pathological response. European Radiology 2024; 34(10) doi: 10.1007/s00330-024-10695-7
|
| 22 |
Sherif Hassanien Ahmed. Safety of neoadjuvant chemotherapy for the treatment of breast cancer. Expert Opinion on Drug Safety 2019; 18(9) doi: 10.1080/14740338.2019.1644318
|